Blood clotting or coagulation is an important mechanism that reduces the blood loss from an injury or any other wound. Hemostats and tissue sealants are used in cases of post-surgery or traumatic injury to bind or hold external tissue (skin) and internal tissues. The North America hemostats and tissue sealants market was valued at $ xx million in 2018 and is expected to grow with CAGR of 7.36% over the forecast period.
NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET FORECAST 2019-2027
North America Hemostats and Tissue Sealants Market by Products (Topical Hemostat (Mechanical Hemostats, Active Hemostats, Flowable Hemostats) Adhesive and Tissue Sealants (Synthetic Tissue Sealant, Oxidized Regenerated Cellulose, Cyanoacrylate Adhesives, Other Synthetic Tissue Sealants) Natural Tissue Sealant( Chitin and Chitosan Based Hemostatic Agent, Other Natural Tissue Sealant, Adhesion Barrier Products & by Geography.
Blood clotting or coagulation is an important mechanism that reduces blood loss from an injury or any other wound. Hemostats and tissue sealants are used in cases of post-surgery or traumatic injury to bind or hold external tissue (skin) and internal tissues. The hemostasis and tissue sealing agents market in North American was valued at $ xx million in 2018 and is expected to grow with CAGR of 7.36% over the forecast period. The North American regional market apprehends the largest share of the hemostasis and tissue sealing agents industry mainly because of rising cases complications like diabetic retinopathy, nephropathy and diabetic foot ulcers which require coagulation treatment.
The North American regional market mainly covers the economies of the United States and Canada. There has been an increase in the number of outpatient surgeries being performed in hospital settings for their cost-effectiveness. The preference of hemostats and sealants over traditional wound closure methods has led to their increased use in multiple conditions, the endoscopic procedures in particular. Although, there have been several side effect cases like fluid accumulation, inhibited bone healing and swelling at the site of the bone graft that is implanted by surgeons to replace degenerated or damaged bone during spinal fusion surgeries. This led to the FDA in the United States to issue a safety communication informing healthcare providers to avoid using bone graft substitutes to underage patients. The US market for hemostats and tissue sealants is both the fastest growing and holds the largest share in this region. This can be attributed to the growing demand for sealants for avoiding the postoperative risk of bleeding by the patients.
There are many market players for the hemostats and tissue sealants market based on the North American region as well as from other regions reaping major profits by revenue. Some of them are: Johnson & Johnson, B.Braun Melsungen AG, Advanced Medical Solutions (AMS) Group PLC, Baxter International Inc., Cohera Medical Inc., C.R. Bard, Inc., Cryolife Inc., CSL Behring, Hyperbranch Medical Technology, Inc. (Acquired by Stryker), Integra Lifesciences Corp., Medtronic PLC, Pfizer, Inc. and Smith & Nephew PLC.
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- TOPICAL HEMOSTAT HOLDS THE LARGEST MARKET SHARE AND IS ANTICIPATED TO GROW AT A FASTER RATE DURING THE FORECAST PERIOD
- SYNTHETIC TISSUE SEALANTS OF THE ADHESIVE AND TISSUE SEALANTS HOLDS THE LARGEST MARKET SHARE
- MARKET DYNAMICS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
- INCREASING INCIDENCE OF CHRONIC DISEASES
- INCREASE IN AGING POPULATION
- INCREASE IN NUMBER OF SURGERIES
- MARKET RESTRAINTS
- STRINGENT REGULATIONS
- ADVERSE REACTIONS AND COMPLICATIONS
- MARKET OPPORTUNITIES
- USAGE OF HEMOSTASIS DEVICES AND TISSUE SEALANTS IN MULTIPLE CONDITIONS
- ACCESSIBILITY OF MORE TREATMENT OPTIONS FOR MEDICAL PROFESSIONALS
- MARKET CHALLENGES
- LIMITATIONS ASSOCIATED WITH HEMOSTATS AND TISSUE SEALANTS
- PRODUCT SIDE EFFECTS AND FDA SCRUTINY
- MARKET BY PRODUCTS
- TOPICAL HEMOSTAT
- MECHANICAL HEMOSTATS
- ACTIVE HEMOSTATS
- FLOWABLE HEMOSTATS
- ADHESIVE AND TISSUE SEALANTS
- SYNTHETIC TISSUE SEALANT
- OXIDIZED REGENERATED CELLULOSE
- CYANOACRYLATE ADHESIVES
- OTHER SYNTHETIC TISSUE SEALANTS
- NATURAL TISSUE SEALANT
- CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT
- OTHER NATURAL TISSUE SEALANT
- ADHESION BARRIER PRODUCTS
- SYNTHETIC TISSUE SEALANT
- TOPICAL HEMOSTAT
- KEY ANALYTICS
- PORTER’S FIVE FORCE MODEL
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTE
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF BUYERS
- THREAT OF COMPETITIVE RIVALRY
- POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL SWOT ANALYSIS OF HEMOSTATS AND TISSUE SEALANTS MARKET
- POLITICAL & LEGAL
- ECONOMIC
- TECHNOLOGICAL
- MARKET TRENDS
- OPPORTUNITY MATRIX
- PORTER’S FIVE FORCE MODEL
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- THE UNITED STATES
- CANADA
- NORTH AMERICA
- COMPETITIVE LANDSCAPE
- MARKET POSITION ANALYSIS
- COMPANY PROFILES
- ADVANCED MEDICAL SOLUTIONS (AMS) GROUP PLC
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- BAXTER INTERNATIONAL INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- BRAUN MELSUNGEN AG
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC ANALYSIS
- COHERA MEDICAL INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- R. BARD, INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- CRYOLIFE INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- CSL BEHRING
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- HYPERBRANCH MEDICAL TECHNOLOGY, INC. (ACQUIRED BY STRYKER)
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- INTEGRA LIFESCIENCES CORP
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- JOHNSON AND JOHNSON
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- MEDTRONIC PLC
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- PFIZER, INC.
- COMPANY PROFILES
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- SMITH AND NEPHEW PLC
- MARKET OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- ZIMMER BIOMET HOLDINGS INC
- MARKET OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- ADVANCED MEDICAL SOLUTIONS (AMS) GROUP PLC
LIST OF TABLES
TABLE 1 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 2 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 3 NORTH AMERICA TOPICAL HEMOSTAT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 4 NORTH AMERICA TOPICAL HEMOSTAT MARKET 2019-2027 ($ MILLION)
TABLE 5 NORTH AMERICA MECHANICAL HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA ACTIVE HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA FLOWABLE HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA ADHESIVE AND TISSUE SEALANTS MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA ADHESIVE AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA SYNTHETIC TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 11 NORTH AMERICA SYNTHETIC TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 12 NORTH AMERICA OXIDIZED REGENERATED CELLULOSE MARKET 2019-2027 ($ MILLION)
TABLE 13 NORTH AMERICA CYANOACRYLATE ADHESIVES MARKET 2019-2027 ($ MILLION)
TABLE 14 NORTH AMERICA OTHER SYNTHETIC TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 15 NORTH AMERICA NATURAL TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 16 NORTH AMERICA NATURAL TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 17 NORTH AMERICA CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT MARKET 2019-2027 ($ MILLION)
TABLE 18 NORTH AMERICA OTHER NATURAL TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 19 NORTH AMERICA ADHESION BARRIER PRODUCTS MARKET BY REAGENTS 2019-2027 ($ MILLION)
TABLE 20 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 21 HEMOSTATS COMPANY MARKET POSITION ANALYSIS 2017 (%)
TABLE 22 TISSUE SEALANTS COMPANY MARKET POSITION ANALYSIS 2017 (%)
LIST OF FIGURES
FIGURE 1 PROCESS OF COAGULATION
FIGURE 2 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET 2018-2026 ($ MILLION)
FIGURE 3 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)
FIGURE 4 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET BY TOPICAL HEMOSTAT 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA TOPICAL HEMOSTAT MARKET BY MECHANICAL HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 6 NORTH AMERICA TOPICAL HEMOSTAT MARKET BY ACTIVE HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 7 NORTH AMERICA TOPICAL HEMOSTAT MARKET BY FLOWABLE HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 8 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET BY ADHESIVE AND TISSUE SEALANTS 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA ADHESIVE AND TISSUE SEALANTS MARKET BY SYNTHETIC TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 10 NORTH AMERICA SYNTHETIC TISSUE SEALANT MARKET BY OXIDIZED REGENERATED CELLULOSE 2019-2027 ($ MILLION)
FIGURE 11 NORTH AMERICA SYNTHETIC TISSUE SEALANT MARKET BY CYANOACRYLATE ADHESIVES 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA SYNTHETIC TISSUE SEALANT MARKET BY OTHER SYNTHETIC TISSUE SEALANTS 2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA ADHESIVE AND TISSUE SEALANTS MARKET BY NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA NATURAL TISSUE SEALANT MARKET BY CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT 2019-2027 ($ MILLION)
FIGURE 15 NORTH AMERICA NATURAL TISSUE SEALANT MARKET BY CHITIN AND OTHER NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA ADHESIVE AND TISSUE SEALANTS MARKET BY ADHESION BARRIER PRODUCTS 2019-2027 ($ MILLION)
FIGURE 17 PORTER’S FIVE FORCE MODEL
FIGURE 18 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 19 THE UNITED STATES HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 20 CANADA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 21 THE UNITED KINGDOM HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- THE UNITED STATES
- CANADA
- NORTH AMERICA
- MARKET BY PRODUCTS
- TOPICAL HEMOSTAT
- MECHANICAL HEMOSTATS
- ACTIVE HEMOSTATS
- FLOWABLE HEMOSTATS
- ADHESIVE AND TISSUE SEALANTS
- SYNTHETIC TISSUE SEALANT
- OXIDIZED REGENERATED CELLULOSE
- CYANOACRYLATE ADHESIVES
- OTHER SYNTHETIC TISSUE SEALANTS
- NATURAL TISSUE SEALANT
- CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT
- OTHER NATURAL TISSUE SEALANT
- ADHESION BARRIER PRODUCTS
- SYNTHETIC TISSUE SEALANT
- TOPICAL HEMOSTAT
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.